![Adrian Cabrera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Cabrera
Directeur/Membre du Conseil chez
Kiniciti
Profil
Adrian Cabrera is currently a Principal at Welsh, Carson, Anderson & Stowe since 2022, and a Board Member at Kiniciti since 2021.
Mr. Cabrera completed undergraduate studies at Florida International University in 2013.
Postes actifs de Adrian Cabrera
| Sociétés | Poste | Début |
|---|---|---|
Welsh, Carson, Anderson & Stowe
 Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements. | Private Equity Investor | 01/07/2019 |
Kiniciti
 Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies | Directeur/Membre du Conseil | 01/01/2021 |
Formation de Adrian Cabrera
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Welsh, Carson, Anderson & Stowe
Welsh, Carson, Anderson & Stowe Investment ManagersFinance WCAS invest in companies located in the United States. The firm targets companies operating in the fields of healthcare and technology sectors. It provide financing for acquisitions and growth capital requirements. | Finance |
Florida International University
 Florida International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniciti
Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies | Technology Services |
